CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale President sold 4,308 shares at $49.21 ($211,997)
- 4 Open-market sale President sold 18,949 shares at $50.07 ($948,729)
- 4 Open-market sale President sold 154,019 shares at an average $50.11 ($7,717,356)
- 4 Open-market buy Director bought 1,050,000 shares at an average $32.05 ($33,652,026)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 10,000 shares at $42.19 ($421,900)
- 4 Open-market sale EVP and CCO sold 105,479 shares at an average $44.46 ($4,689,263)
- 4 Open-market sale EVP & General Counsel sold 17,500 shares at $45.06 ($788,576)
- 4 Open-market sale EVP and CCO sold 14,521 shares at an average $50.46 ($732,792)
- 4 Open-market sale EVP and CFO sold 36,000 shares at an average $49.66 ($1,787,853)
- 4 Open-market sale CEO sold 150,000 shares at an average $52.34 ($7,851,300)
- 4 Open-market sale President sold 2,160 shares at $46.41 ($100,246)
- 4 Open-market sale Controller & PAO sold 147 shares at $39.65 ($5,829)
- 4 Open-market sale EVP and CCO sold 877 shares at $39.65 ($34,773)
- 4 Open-market sale President sold 1,031 shares at $39.65 ($40,879)
- 4 Open-market sale CEO sold 2,983 shares at $39.65 ($118,276)
Page 13 of 35 · 686 filings